Cannabis-related disorders and toxic effects

DA Gorelick - New England Journal of Medicine, 2023 - Mass Medical Soc
Cannabis-Related Disorders and Toxic Effects | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …

Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer's disease

M Coles, GZ Steiner-Lim, T Karl - Frontiers in Neuroscience, 2022 - frontiersin.org
Alzheimer's disease (AD) is a debilitating neurodegenerative disease characterized by
declining cognition and behavioral impairment, and hallmarked by extracellular amyloid-β …

Phase IIb randomized, placebo-controlled, dose-escalating, double-blind study of cannabidiol oil for the relief of symptoms in advanced cancer (MedCan1-CBD)

J Hardy, R Greer, G Huggett, A Kearney… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE To determine whether cannabidiol (CBD) oil can improve symptom distress in
patients with advanced cancer receiving palliative care. METHODS Participants were adults …

[HTML][HTML] Are blood and oral fluid Δ9-tetrahydrocannabinol (THC) and metabolite concentrations related to impairment? A meta-regression analysis

D McCartney, TR Arkell, C Irwin, RC Kevin… - Neuroscience & …, 2022 - Elsevier
Blood and oral fluid Δ 9-tetrahydrocannabinol (THC) concentrations are often used to
identify cannabis-impaired drivers. We used meta-analytic techniques to characterise the …

A primer on medicinal cannabis safety and potential adverse effects

JC Arnold - Australian journal of general practice, 2021 - search.informit.org
Background: Medicinal cannabis prescriptions are on the rise in Australia, and general
practitioners will increasingly encounter patients using cannabis-based products. Objective …

Driving under the influence of cannabis: impact of combining toxicology testing with field sobriety tests

RL Fitzgerald, A Umlauf, JA Hubbard… - Clinical …, 2023 - academic.oup.com
Background Cannabis is increasingly used both medically and recreationally. With
widespread use, there is growing concern about how to identify cannabis-impaired drivers …

Oral cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: Final results of a randomized, placebo-controlled, phase II/III trial

P Grimison, A Mersiades, A Kirby, A Tognela… - Journal of Clinical …, 2024 - ascopubs.org
PURPOSE The aim of this randomized, placebo-controlled, two-stage, phase II/III trial was to
determine the efficacy of an oral cannabis extract in adults with refractory nausea and/or …

Cannabis self-administration in the human laboratory: a sco** review of ad libitum studies

KB **ao, E Grennell, A Ngoy, TP George, B Le Foll… - …, 2023 - Springer
Cannabis self-administration studies may be helpful for identifying factors that influence
cannabis consumption and subjective response to cannabis. Additionally, these paradigms …

The “next day” effects of cannabis use: a systematic review

D McCartney, A Suraev, IS McGregor - Cannabis and cannabinoid …, 2023 - liebertpub.com
Background: Δ9-Tetrahydrocannabinol (THC), the main intoxicating component of cannabis,
can cause cognitive and psychomotor impairment. Whether this impairment is still present …

Driving-related behaviors, attitudes, and perceptions among Australian medical cannabis users: results from the CAMS 20 survey

TR Arkell, SV Abelev, L Mills, A Suraev… - Journal of cannabis …, 2023 - Springer
Road safety is an important concern amidst expanding worldwide access to legal cannabis.
The present study reports on the driving-related subsection of the Cannabis as Medicine …